Abstract
The design, synthesis, and biological evaluation of a series of epothilone analogues with novel side chains equipped with an amino group are described. Their design facilitates potential conjugation to selective drug delivery systems such as antibodies. Their synthesis proceeded efficiently via Stille coupling of a readily available vinyl iodide and heterocyclic stannanes. Cytotoxicity studies and tubulin binding assays revealed two of these analogues to be more potent than epothilones A-D and the anticancer agent ixabepilone, currently in clinical use.
Keywords:
antibody-drug conjugates; anticancer agents; epothilones; organic synthesis; tubulin binding agents.
© 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antibodies / chemistry
-
Antineoplastic Agents / chemical synthesis*
-
Antineoplastic Agents / metabolism
-
Antineoplastic Agents / pharmacology
-
Catalysis
-
Cell Line, Tumor
-
Cell Survival / drug effects
-
Coordination Complexes / chemistry
-
Drug Carriers / chemistry
-
Drug Design
-
Drug Screening Assays, Antitumor
-
Epothilones / chemistry*
-
Epothilones / metabolism
-
Epothilones / pharmacology
-
Humans
-
Protein Binding
-
Structure-Activity Relationship
-
Tin Compounds / chemistry
-
Tubulin / chemistry
-
Tubulin / metabolism
-
Vinyl Compounds / chemistry
Substances
-
Antibodies
-
Antineoplastic Agents
-
Coordination Complexes
-
Drug Carriers
-
Epothilones
-
Tin Compounds
-
Tubulin
-
Vinyl Compounds
-
vinyl iodide
-
stannane
-
epothilone B